Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
175M
-
Number of holders
-
354
-
Total 13F shares, excl. options
-
86.2M
-
Shares change
-
+3.17M
-
Total reported value, excl. options
-
$5.71B
-
Value change
-
+$229M
-
Put/Call ratio
-
1.78
-
Number of buys
-
209
-
Number of sells
-
-133
-
Price
-
$66.41
Significant Holders of Teladoc Health, Inc. - Common Stock (TDOC) as of Q2 2019
439 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock as of Q2 2019.
Teladoc Health, Inc. - Common Stock (TDOC) has 354 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86.2M shares
of 175M outstanding shares and own 49.15% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.6M shares), VANGUARD GROUP INC (6.29M shares), JPMORGAN CHASE & CO (5.95M shares), WELLINGTON MANAGEMENT GROUP LLP (3.06M shares), JANUS HENDERSON GROUP PLC (2.99M shares), ALLIANCEBERNSTEIN L.P. (2.62M shares), WADDELL & REED FINANCIAL INC (2.34M shares), BANK OF AMERICA CORP /DE/ (2.27M shares), ZEVENBERGEN CAPITAL INVESTMENTS LLC (1.98M shares), and RIVERBRIDGE PARTNERS LLC (1.75M shares).
This table shows the top 354 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.